DXSP DXS International PLC

Director/PDMR Shareholding

Director/PDMR Shareholding
EN
01/10/2020

Underlying

DXSPDXS International PLC

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on DXS International PLC

Hybridan Team ... (+2)
  • Hybridan Team
  • Jon Levinson
DXSP DXS Internation...

Hybridan Research: DXS International PLC

Good Afternoon, DXS International PLC (AQSE:DXSP) announced Interims to 31 October 2025. We have published research on this which is attached and a snapshot of the research is below.

DXSP DXS INTERNATIONAL PLC
01/28/26 January 28, 2026 1 EN
Hybridan Team ... (+2)
  • Hybridan Team
  • Jon Levinson
PEB Pebble Beach Sy...
PGH Personal Group ... ... (+11)

Hybridan Small Cap Feast: 28 January 2026

28th January 2026 @HybridanLLP Our daily digest of news from UK Small Caps * A corporate client of Hybridan LLP. ** Potential means Intention to Float (ITF) or similar announcement has been made. ***Arranged by type of listing and date of announcement. ****Alphabetically arranged and priced on Share Price and Market Capitalisation during the time of writing on the day of Publication. Dish of the Day Admissions: Following a Reverse Tak...

PEB PEBBLE BEACH SYSTEMS GROUP
PGH PERSONAL GROUP HOLDINGS PLC
MLVN MALVERN INTERNATIONAL
SML STRATEGIC MINERALS
PYC PHYSIOMICS PLC
DXSP DXS INTERNATIONAL PLC
AXL. ARROW EXPLORATION LTD
MEX TORTILLA MEXICAN GRILL PLC
PEBB PEBBLE GROUP PLC (THE)
KOO KOOTH PLC
CRDL CORDEL GROUP PLC
01/28/26 January 28, 2026 1 EN
 PRESS RELEASE
Free
DXSP DXS Internation...

DXS International plc (AQSE: DXSP): Half-year Financial Report

DXS International plc (AQSE: DXSP): Half-year Financial Report DXS INTERNATIONAL PLC (AQSE: DXSP) HALF YEAR RESULTS DXS International plc ("DXS" or the "Company"), the digital clinical decision support company, is pleased to provide shareholders with its unaudited interim results for the half year ending 31 October 2025. H1 2025 Financial highlights: Core recurring revenue model remains resilient. Revenue decreased by 2.6% to £1,684,712 (H1 2024 - £1,730,829) in the six months to 31 October 2025 ("Period"). Administration costs decreased by 5% in the Period (H1 2024 -£87,474)Loss afte...

January 28, 2026 1 EN
 PRESS RELEASE
Free
DXSP DXS Internation...

DXS International plc (AQSE: DXSP) Update on Cyber Security Incident

DXS International plc (AQSE: DXSP) Update on Cyber Security Incident 24 December 2025 DXS INTERNATIONAL PLC (AQSE: DXSP) Update on Cyber Security Incident The Board of DXS International plc (“the Company” or “DXSP”), the AQSE Growth Market quoted healthcare information and digital clinical decision support systems provider, would like to provide an update on the security incident that affected its office servers, which was reported via RNS on 18 December. The incident has been contained, and DXS remains vigilant by implementing additional monitoring and security measures.  The Director...

December 24, 2025 1 EN
 PRESS RELEASE
Free
DXSP DXS Internation...

DXS INTERNATIONAL PLC (AQSE: DXSP) Result of AGM

DXS INTERNATIONAL PLC (AQSE: DXSP) Result of AGM 19 December 2025 DXS INTERNATIONAL PLC (AQSE: DXSP) Result of DXS AGM 2025 The Board of DXS International plc (“the Company” or “DXSP”), the AQSE Growth Market quoted healthcare information and digital clinical decision support systems provider, is pleased to announce that all resolutions put to shareholders at the Company's Annual General Meeting ("AGM") held yesterday were duly passed. All resolutions were passed on a poll and the votes received from shareholders on each resolution put to the AGM are set out below. ResolutionVotes For *...

December 19, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch